Good Life Advisors, LLC Amgen Inc Transaction History

Good Life Advisors, LLC

$1.58 Billion
Q3 2024

A detailed history of Good Life Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Good Life Advisors, LLC holds 1,651 shares of AMGN stock, worth $471,228. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,651

Previous 1,408 17.26%

Holding current value

$471,228

Previous $439,000 20.96%

% of portfolio

0.03%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$309.38 - $337.38 $75,179 - $81,983	243 Added 17.26%	1,651 $531,000
Q2 2024 Jul 17, 2024	BUY	$262.75 - $319.31 $44,404 - $53,963	169 Added 13.64%	1,408 $439,000
Q1 2024 May 02, 2024	SELL	$268.87 - $324.56 $51,085 - $61,666	-190 Reduced 13.3%	1,239 $352,000
Q4 2023 Jan 18, 2024	SELL	$255.7 - $288.46 $32,218 - $36,345	-126 Reduced 8.1%	1,429 $411,000
Q3 2023 Oct 19, 2023	SELL	$218.65 - $271.46 $21,865 - $27,145	-100 Reduced 6.04%	1,555 $417,000
Q2 2023 Jul 10, 2023	BUY	$214.27 - $253.37 $13,070 - $15,455	61 Added 3.83%	1,655 $367,000
Q1 2023 May 05, 2023	SELL	$225.79 - $275.2 $451 - $550	-2 Reduced 0.13%	1,594 $385,000
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $8,016 - $10,185	35 Added 2.24%	1,596 $419,000
Q3 2022 Oct 13, 2022	BUY	$224.46 - $253.15 $56,339 - $63,540	251 Added 19.16%	1,561 $352,000
Q2 2022 Jul 19, 2022	BUY	$230.71 - $256.74 $5,075 - $5,648	22 Added 1.71%	1,310 $319,000
Q1 2022 Apr 26, 2022	SELL	$219.27 - $242.57 $1,315 - $1,455	-6 Reduced 0.46%	1,288 $311,000
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $5,966 - $6,828	-30 Reduced 2.27%	1,294 $291,000
Q3 2021 Oct 29, 2021	BUY	$212.27 - $248.7 $64,317 - $75,356	303 Added 29.68%	1,324 $282,000
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $238,485 - $264,581	1,021 New	1,021 $249,000
Q4 2020 Feb 04, 2021	SELL	$216.38 - $257.67 $180,028 - $214,381	-832 Closed	0 $0
Q3 2020 Oct 19, 2020	SELL	$234.65 - $260.95 $25,811 - $28,704	-110 Reduced 11.68%	832 $214,000
Q2 2020 Jul 20, 2020	BUY	$197.81 - $242.74 $186,337 - $228,661	942 New	942 $222,000
Q1 2020 May 01, 2020	SELL	$182.24 - $241.7 $171,305 - $227,198	-940 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$189.21 - $243.2 $177,857 - $228,608	940 New	940 $227,000
Q1 2019 May 09, 2019	SELL	$180.87 - $203.88 $237,844 - $268,102	-1,315 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$178.4 - $208.25 $32,647 - $38,109	-183 Reduced 12.22%	1,315 $256,000
Q3 2018 Oct 26, 2018	SELL	$185.29 - $208.89 $146,934 - $165,649	-793 Reduced 34.61%	1,498 $312,000
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $79,371 - $89,151	-478 Reduced 17.26%	2,291 $422,000
Q1 2018 May 01, 2018	BUY	$169.43 - $198.0 $2,202 - $2,574	13 Added 0.47%	2,769 $456,000
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $4,894 - $5,469	29 Added 1.06%	2,756 $497,000
Q3 2017 Nov 01, 2017	SELL	$167.29 - $191.0 $43,160 - $49,278	-258 Reduced 8.64%	2,727 $505,000
Q2 2017 Aug 08, 2017	BUY	N/A	2,985	2,985 $515,000

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

401M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $153B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Good Life Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Good Life Advisors, LLC with notifications on news.

Account

Good Life Advisors, LLC Amgen Inc Transaction History